- Home
- BRBR vs KRYS Comparison
BRBR vs KRYS Comparison
Compare BRBR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBR
- KRYS
- Stock Information
- Founded
- BRBR 2019
- KRYS 2015
- Country
- BRBR United States
- KRYS United States
- Employees
- BRBR N/A
- KRYS N/A
- Industry
- BRBR Packaged Foods
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRBR Consumer Staples
- KRYS Health Care
- Exchange
- BRBR Nasdaq
- KRYS Nasdaq
- Market Cap
- BRBR 4.5B
- KRYS 4.7B
- IPO Year
- BRBR 2019
- KRYS 2017
- Fundamental
- Price
- BRBR $34.29
- KRYS $184.01
- Analyst Decision
- BRBR Buy
- KRYS Strong Buy
- Analyst Count
- BRBR 17
- KRYS 9
- Target Price
- BRBR $65.76
- KRYS $203.22
- AVG Volume (30 Days)
- BRBR 2.5M
- KRYS 372.0K
- Earning Date
- BRBR 11-17-2025
- KRYS 11-03-2025
- Dividend Yield
- BRBR N/A
- KRYS N/A
- EPS Growth
- BRBR 5.53
- KRYS 36.22
- EPS
- BRBR 1.75
- KRYS 4.91
- Revenue
- BRBR $2,224,200,000.00
- KRYS $359,205,000.00
- Revenue This Year
- BRBR $17.62
- KRYS $34.33
- Revenue Next Year
- BRBR $9.80
- KRYS $47.84
- P/E Ratio
- BRBR $19.48
- KRYS $37.00
- Revenue Growth
- BRBR 16.27
- KRYS 116.08
- 52 Week Low
- BRBR $33.73
- KRYS $122.80
- 52 Week High
- BRBR $80.67
- KRYS $207.84
- Technical
- Relative Strength Index (RSI)
- BRBR 35.48
- KRYS 68.30
- Support Level
- BRBR $33.73
- KRYS $179.80
- Resistance Level
- BRBR $35.51
- KRYS $190.01
- Average True Range (ATR)
- BRBR 1.09
- KRYS 6.01
- MACD
- BRBR 0.11
- KRYS 0.55
- Stochastic Oscillator
- BRBR 21.36
- KRYS 81.19
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.